All Articles

A new framework signals a major shift from message control to radical transparency. Here's why brands that embrace authenticity will win in a skeptical market.

A new partnership combines C12's novel carbon nanotube qubits with Classiq's agile software, creating a vital link to unlock practical quantum computing.

Global consulting firm Korn Ferry takes on the monumental task of building the 5,000-person team for the LA28 Olympic and Paralympic Games.

ENNOVI's Tijuana expansion offers a key nearshoring solution for medical device makers, tackling complex regulations and streamlining North American supply chains.

An $8.75 billion merger was meant to create a building giant. Instead, a 35% stock crash has sparked a securities investigation into James Hardie.

A new drug targeting a genetic form of Parkinson's shows promise as its late-stage trial nears completion, offering hope for a precision treatment.

The Don Pepino owner is buying the organic tomato brand from General Mills, a strategic move set to reshape the competitive $5 billion tomato products aisle.

A new report from a top analyst reveals how chaotic yard operations are silently draining profits and creating massive risks for shippers across the globe.

A new report reveals U.S. restaurants are overcoming financial strain, shedding debt, and hitting double-digit profit margins by embracing technology.

BioTalent Canada's latest awards highlight how inclusivity, diversity, and equity are becoming key drivers of innovation and profit in the bioscience sector.

New research provides the strongest human evidence that sleep actively clears toxic proteins linked to Alzheimer's, opening a new frontier for prevention.

Libraesva and Cyber Guru combine to tackle the human element in cybersecurity, aiming to create a European leader against US giants in a growing market.

A strategic partnership between MEXC Ventures and local giant TRIV signals a new era for crypto in Indonesia, blending global tech with a decade of local trust.

A Norwegian firm's new AI software aims to reduce physician distractions and build trust, setting a new standard for cancer-detecting technology.

Veteran leader Emma Rooth takes charge at PCCA UK, bringing a track record of transformation to the booming personalized medicine market.

A new report reveals 84% of high-risk firms are unprepared for insider threats as state actors increasingly target the human factor within organizations.

China approves Libevitug, a first-in-class drug for the most severe form of hepatitis, marking a major milestone for patients and global biotech innovation.

With drug pipelines facing staggering failure rates, HKeyBio's new preclinical strategy aims to de-risk R&D and accelerate effective new treatments.

Hong Kong's first CSI A500 ETF is set to launch, offering a new, diversified way for global investors to tap into 500 of China's leading A-shares.

A Dubai-based PR firm leverages Web Summit Qatar to challenge industry giants, blending SEO with traditional newswire for the AI and Web3 era.